UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With

UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses on
Their Investment in Peregrine Pharmaceuticals, Inc. of Class Action
Lawsuit and the Deadline of November 27, 2012 to Seek a Lead
Plaintiff Position 
NEW YORK, NY -- (Marketwire) -- 11/21/12 --  Levi & Korsinsky
announces that a class action lawsuit has been commenced in the
United States District Court for the Central District of California
on behalf of investors who acquired Peregrine Pharmaceuticals, Inc.
("Peregrine" or the "Company") (NASDAQ: PPHM) securities between
August 30, 2012 and September 26, 2012. 
For more information, click here:
http://zlk.9nl.com/peregrine-pharmaceuticals-pphm/. There is no cost
or obligation to you. 
The complaint alleges that throughout the Class Period the defendants
issued false and/or misleading statements or failed to disclose
material adverse facts about Peregrine's business and financial
prospects, including that: (a) there were major discrepancies between
some patient sample test results and patient treatment code
assignments; (b) as such, the clinical data from the Company's Phase
II trial of its drug bavituximab was unreliable; and (c) as result of
the foregoing, the defendants' positive statements about Peregrine's
business, operations, and prospects lacked a reasonable basis.  
On September 24, 2012 Peregrine disclosed the discovery of major
discrepancies between some patient sample test results and patient
treatment code assignments, and acknowledged that as a result of
these discrepancies, previously reported clinical data from its Phase
II trial could no longer be relied upon. Upon this news, Peregrine
shares declined 78.48% to close at $1.16 per share on September 24,
2012. 
If you suffered a loss in Peregrine you have until November 27, 2012
to request that the Court appoint you as lead plaintiff. Your ability
to share in any recovery doesn't require that you serve as a lead
plaintiff. To obtain additional information, contact Joseph E. Levi,
Esq. either via email at jlevi@zlk.com or by telephone at (877)
363-5972, or visit
http://zlk.9nl.com/peregrine-pharmaceuticals-pphm/. 
Levi & Korsinsky is a national firm with offices in New York and
Washington D.C. The firm has extensive expertise in prosecuting
securities litigation involving financial fraud, representing
investors throughout the nation in securities and shareholder
lawsuits. Attorney advertising. Prior results do not guarantee
similar outcomes. 
CONTACT: 
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor 
New York, NY 10004 
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com 
 
 
Press spacebar to pause and continue. Press esc to stop.